Global Brain

Activity from announced rounds

Activity in this selectionApr 30, 2026 · Apr 1, 2026

Global Brain is a Japanese investment corporation, also recorded under the expanded name Global Brain Corporation.

Recorded funding activity

The firm’s own announcements connect it to WED’s receipt-based marketing and RegCell’s cell therapies for autoimmune disease. Other covered activity includes 10pct.’s combination of hotel operations and AI software. Named corporate and flagship funds remain separate.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$17.7M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Hardware1

By country

Sweden1

Rounds

1 in this selection
AlixLabs

AlixLabs develops atomic-layer etching processes and equipment for semiconductor manufacturers making smaller, more densely packed chip features.

€15MSeries A
Participant